10-01-2026 09:34 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Historical Volume
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 375.73
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 908067.96
P/E 54.36
EPS 40.47
Face Value 1  
Exchange : Period From : To :
DateOpen PriceHigh PriceLow PriceClose PriceVolumeTurnover
09-Jan-2026 2241.25 2252.00 2186.55 2199.75 6889 15253748
08-Jan-2026 2320.00 2320.00 2251.10 2256.70 10020 22814879
07-Jan-2026 2257.75 2320.45 2232.55 2311.60 67041 153529374
06-Jan-2026 2231.10 2248.85 2189.10 2241.85 13582 30257946
05-Jan-2026 2222.65 2222.65 2185.05 2193.45 3458 7619060
02-Jan-2026 2178.85 2205.35 2164.00 2202.55 2524 5518322
01-Jan-2026 2213.50 2213.50 2160.00 2163.10 2273 4934406
Page 1 of 1
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.